Global Journal of Nanomedicine (GJN)

Global Journal of Nanomedicine (GJN) desires to deliver research and clinically reformative information globally. GJN is an open access, peer-reviewed, multidisciplinary, international medical journal published bimonthly by Juniper group. GJN covers research on the application of nanoscience and nanotechnology in diagnostics, therapeutics, and drug delivery systems throughout the biomedical field. GJN publishes novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life sciences. Article formats include Communications, Original Articles, Reviews, Perspectives, Technical and Commercialization Notes, Letters to the Editor, and Case Reports. We invite authors to submit original manuscripts in these categories. GJN is a scientific journal which provides an opportunity to share the information among the medical scientists and researchers. Articles published here are freely available through online without any restrictions or any other subscriptions to researchers worldwide. The journal covers a broad range of topics including nanomaterials, nanodrugs, targeted drug delivery, nanodiagnostics, biomedical imaging, cancer nanotechnology, regenerative medicine, and nanotoxicology. It accepts various article types such as original research articles, reviews, case reports, short communications, and perspectives. GJN aims to bridge the gap between nanoscience and clinical medicine by encouraging innovative research that improves disease diagnosis and treatment strategies. Through its open-access model, the journal ensures global visibility and free access to scientific knowledge for researchers and healthcare professionals worldwide. It also promotes interdisciplinary collaboration across chemistry, biology, engineering, and medical sciences, contributing to the rapid development of nanotechnology-based healthcare solutions.

Global Journal of Nanomedicine (GJN) is :-

• International, Peer-Reviewed, Open Access, Refereed, Nanomedicine, Nanotechnology, Drug Delivery Systems, Biomedical Engineering, Cancer Nanotechnology, Nanotoxicology, nanomaterials, nanodrugs, targeted drug delivery, nanodiagnostics, biomedical imaging, cancer nanotechnology, regenerative medicine, nanotoxicology, original research articles, reviews, case reports, short communications, perspectives , Online , Bi-Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2573-2374, Established: 2016, Impact Factor: 0.6
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE